Amicogen, Inc. (KOSDAQ: A092040)
Health Care · Biotechnology · KR
₩924.00
-6.29% today · -73.3% 1Y
Amicogen, Inc. (KOSDAQ: A092040) operates in the Biotechnology industry within the Health Care sector. The company is valued at $48.83M.
Over the last twelve months the share price has lost 73.3%, trading between 787.00 and 3.57K.
Tweenvest scores Amicogen, Inc. across four factors: quality 48/100, value 73/100. Its strongest factor is value.
A092040 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $48.83M
- Revenue (TTM)
- $30.15M
- P/E
- —
- EPS
- -315.47
- Dividend yield
- —
- Beta (5Y)
- 0.16
- 52-week high
- ₩3,570.00
- 52-week low
- ₩787.00
- Avg volume (3M)
- —
- Shares outstanding
- 70.45M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| iBio, Inc.NasdaqCM: IBIO | $49.28M | $0.77 | -12.02% |
| Xspray Pharma AB (publ)OM: XSPRAY | $49.23M | Skr10.30 | -3.92% |
| Adicet Bio, Inc.NasdaqCM: ACET | $49.19M | $4.57 | -18.54% |
| PanGen Biotech Inc.KOSDAQ: A222110 | $49.11M | ₩4,845.00 | +3.75% |
| Optipharm.CO.,LTDKOSDAQ: A153710 | $48.80M | ₩4,435.00 | -1.22% |
| GENINUS Inc.KOSDAQ: A389030 | $48.75M | ₩1,650.00 | -15.38% |
| MiNK Therapeutics, Inc.NasdaqCM: INKT | $48.02M | $9.41 | -12.22% |
| Connect Biopharma Holdings LimitedNasdaqGM: CNTB | $47.99M | $0.76 | -4.51% |
Figures last refreshed Oct 18, 2026.